ARDX
ARDELYX, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.29
+8.58%Margins
Gross margin
94.3%
EBITDA margin
-6.1%
EBIT margin
-7.7%
Net margin
-11.8%
FCF margin
-3.4%
-33.8%
Return on equity
-9.4%
Return on assets
-8.6%
Return on invested capital
0.80x
Asset turnover
-$15.5M
Cash from operations
$1.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026